相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Contrasting ABCB1 pharmacogenetics and psychotropic responses in child and adolescent psychiatry: a case comparison
Pragya Kalla et al.
PHARMACOGENOMICS (2023)
Dopamine in Autism Spectrum Disorders-Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment
Vanja Mandic-Maravic et al.
FRONTIERS IN PSYCHIATRY (2022)
Cellular and molecular mechanisms underlying autism spectrum disorders and associated comorbidities: A pathophysiological review
Hussain Al Dera
BIOMEDICINE & PHARMACOTHERAPY (2022)
Pharmacogenomics in clinical practice to prevent risperidone-induced hyperprolactinemia in autism spectrum disorder
Mohitosh Biswas et al.
PHARMACOGENOMICS (2022)
Management of psychotropic medications in adults with intellectual disability: a scoping review
Ashley Costello et al.
ANNALS OF MEDICINE (2022)
Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review: etudes Pharmacogenomiques en Deficiences Intellectuelles et Trouble du Spectre de L'autisme: Une Revue Systematique
Kazunari Yoshida et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2021)
Neuropsychological Profile, Emotional/Behavioral Problems, and Parental Stress in Children with Neurodevelopmental Disorders
Francesca Felicia Operto et al.
BRAIN SCIENCES (2021)
Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic
Karla Claudio-Campos et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Gender based differences, pharmacogenetics and adverse events in chronic pain management
Beatriz Planelles et al.
PHARMACOGENOMICS JOURNAL (2020)
The potential impact of COMT gene variants on dopamine regulation and phenotypic traits of ASD patients
Nora N. Esmaiel et al.
BEHAVIOURAL BRAIN RESEARCH (2020)
Pharmacotherapy of restricted/repetitive behavior in autism spectrum disorder:a systematic review and meta-analysis
Yanjie Yu et al.
BMC PSYCHIATRY (2020)
Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up
Sylvie Bernaerts et al.
MOLECULAR AUTISM (2020)
Pharmacogenomics and Personalized Medicine
Erika Cecchin et al.
GENES (2020)
Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability
Cristina Espadas et al.
PSYCHIATRY RESEARCH (2020)
A Randomized, Placebo-Controlled, Blinded, Crossover, Pilot Study of the Effects of Dextromethorphan/Quinidine for the Treatment of Neurobehavioral Symptoms in Adults with Autism
Michael Chez et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2020)
Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism
Keiho Owada et al.
BRAIN (2019)
A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder
Federico Bolognani et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD)
Charlotte M. Pretzsch et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability
Pura Ballester et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Modulation of brain activation during executive functioning in autism with citalopram
Robert H. Wichers et al.
TRANSLATIONAL PSYCHIATRY (2019)
BDNF 196 G/A and COMT Val158Met Polymorphisms and Susceptibility to ADHD: A Meta-Analysis
Young Ho Lee et al.
JOURNAL OF ATTENTION DISORDERS (2018)
Classics in Chemical Neuroscience: Risperidone
Trevor C. Chopko et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants
Miriam Saiz-Rodriguez et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
Nermin Eissa et al.
FRONTIERS IN NEUROSCIENCE (2018)
Effects of acute beta-adrenergic antagonism on verbal problem solving in autism spectrum disorder and exploration of treatment response markers
Rachel M. Zamzow et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2017)
A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder
Daniel Umbricht et al.
NEUROPSYCHOPHARMACOLOGY (2017)
GeneAnalytics Pathway Analysis and Genetic Overlap among Autism Spectrum Disorder, Bipolar Disorder and Schizophrenia
Naveen S. Khanzada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Pharmacogenomics of autism spectrum disorder
Jacob T. Brown et al.
PHARMACOGENOMICS (2017)
Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial
D. S. Quintana et al.
TRANSLATIONAL PSYCHIATRY (2017)
Restoring effects of oxytocin on the attentional preference for faces in autism
M. Kanat et al.
TRANSLATIONAL PSYCHIATRY (2017)
What is needed to incorporate clinical pharmacogenetic tests into the practice of psychopharmacotherapy?
Jose de Leon et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
Psychopharmacological interventions in autism spectrum disorder
Robert E. Accordino et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study
Barbara Breitenstein et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study
Rachel M. Zamzow et al.
PSYCHOPHARMACOLOGY (2016)
Do blood plasma levels of oxytocin moderate the effect of nasally administered oxytocin on social orienting in high-functioning male adults with autism spectrum disorder?
Monika Althaus et al.
PSYCHOPHARMACOLOGY (2016)
Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism
Takamitsu Watanabe et al.
BRAIN (2015)
Oxytocin enhances orienting to social information in a selective group of high-functioning male adults with autism spectrum disorder
M. Althaus et al.
NEUROPSYCHOLOGIA (2015)
Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism
B. Auyeung et al.
TRANSLATIONAL PSYCHIATRY (2015)
COMT Genotype Affects Brain White Matter Pathways in Attention-Deficit/Hyperactivity Disorder
Soon-Beom Hong et al.
HUMAN BRAIN MAPPING (2015)
The health status of adults on the autism spectrum
Lisa A. Croen et al.
AUTISM (2015)
Adjustment of the UKU Side Effect Rating Scale for adults with intellectual disabilities. A pilot study
Anne Louise Tveter et al.
ADVANCES IN MENTAL HEALTH AND INTELLECTUAL DISABILITIES (2014)
A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders
Eric Hollander et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
D2 Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis
Jian-Ping Zhang et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
The role of CYP2D6 and ABCB1 pharmacogenetics in drug-na⟨ve patients with first-episode schizophrenia treated with risperidone
Nikolina Jovanovic et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Emerging drugs for the treatment of symptoms associated with autism spectrum disorders
Logan K. Wink et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions
C. T. Correia et al.
PHARMACOGENOMICS JOURNAL (2010)
Association of COMT (Val158Met) and BDNF (Val66Met) Gene Polymorphisms with Anxiety, ADHD and Tics in Children with Autism Spectrum Disorder
Kenneth D. Gadow et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2009)
Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting
Malin Alenius et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Clinical applications of pharmacogenetics in psychiatry
S Staddon et al.
PSYCHOPHARMACOLOGY (2002)